plerixafor has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Lu, H; Sheng, X; Xia, R; Xu, G; Xu, X | 1 |
| Archibald, SJ; Bates, J; Hubin, TJ; Jin, J; Lauderdale, J; Panneerselvam, J; Ramesh, R; Shanker, M; Wang, Q; Zhao, YD | 1 |
| Jin, YB; Jung, JE; Jung, MJ; Kim, YM; Ko, YG; Lee, JC; Lee, JS; Lee, SJ; Park, MJ; Rho, JK | 1 |
3 other study(ies) available for plerixafor and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Benzylamines; Carcinoma, Non-Small-Cell Lung; Cell Movement; Chemokine CXCL12; Chemotaxis; Cyclams; Dose-Response Relationship, Drug; Hesperidin; Heterocyclic Compounds; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Proteins; Receptors, CXCR4; Signal Transduction; Wound Healing | 2018 |
IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Topics: Benzylamines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Drug Synergism; Gene Expression; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Interleukins; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
Topics: Animals; Benzylamines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Drug Resistance, Neoplasm; Female; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Mice, Nude; Mice, SCID; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Receptors, CXCR4; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Tyrphostins; Up-Regulation | 2013 |